HLA Class II Genes Interact with the Immune Correlates from the RV144 Vaccine Efficacy Trial and Impact HIV-1 Acquisition

被引：0
|
作者：
Prentice, H. [7 ]
Geraghty, D. E. [1 ]
Tomaras, G. D. [2 ]
Fong, Y. [1 ]
Nelson, W. [1 ]
Kijak, G. H. [7 ]
Zolla-Pazner, S. [3 ]
Nitayaphan, S. [4 ]
Rerks-Ngarm, S. [5 ]
Kaewkungwal, J. [6 ]
Pitisuttithum, P. [6 ]
Gilbert, P. B. [1 ]
Haynes, B. F. [2 ]
Kim, J. H. [7 ]
Michael, N.
Thomas, R.
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Duke Univ, Sch Med, Durham, NC USA
[3] NYU, Sch Med, New York, NY USA
[4] US Army Med Component, AFRIMS, Bangkok, Thailand
[5] Minist Publ Hlth, Nonthanburi, Thailand
[6] Mahidol Univ, Bangkok 10700, Thailand
[7] US MHRP, Silver Spring, MD USA
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 2013年 / 29卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：A178 / A178
页数：1
相关论文
共 50 条
  • [21] Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
    Haynes, Barton F.
    Gilbert, Peter B.
    McElrath, M. Juliana
    Zolla-Pazner, Susan
    Tomaras, Georgia D.
    Alam, S. Munir
    Evans, David T.
    Montefiori, David C.
    Karnasuta, Chitraporn
    Sutthent, Ruengpueng
    Liao, Hua-Xin
    DeVico, Anthony L.
    Lewis, George K.
    Williams, Constance
    Pinter, Abraham
    Fong, Youyi
    Janes, Holly
    DeCamp, Allan
    Huang, Yunda
    Rao, Mangala
    Billings, Erik
    Karasavvas, Nicos
    Robb, Merlin L.
    Ngauy, Viseth
    de Souza, Mark S.
    Paris, Robert
    Ferrari, Guido
    Bailer, Robert T.
    Soderberg, Kelly A.
    Andrews, Charla
    Berman, Phillip W.
    Frahm, Nicole
    De Rosa, Stephen C.
    Alpert, Michael D.
    Yates, Nicole L.
    Shen, Xiaoying
    Koup, Richard A.
    Pitisuttithum, Punnee
    Kaewkungwal, Jaranit
    Nitayaphan, Sorachai
    Rerks-Ngarm, Supachai
    Michael, Nelson L.
    Kim, Jerome H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (14): : 1275 - 1286
  • [22] Statistical Interpretation of the RV144 HIV Vaccine Efficacy Trial in Thailand: A Case Study for Statistical Issues in Efficacy Trials
    Gilbert, Peter B.
    Berger, James O.
    Stablein, Donald
    Becker, Stephen
    Essex, Max
    Hammer, Scott M.
    Kim, Jerome H.
    DeGruttola, Victor G.
    JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (07): : 969 - 975
  • [23] HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trial
    Heather A. Prentice
    Philip K. Ehrenberg
    Karen M. Baldwin
    Aviva Geretz
    Charla Andrews
    Sorachai Nitayaphan
    Supachai Rerks-Ngarm
    Jaranit Kaewkungwal
    Punnee Pitisuttithum
    Robert J. O’Connell
    Merlin L. Robb
    Jerome H. Kim
    Nelson L. Michael
    Rasmi Thomas
    Immunogenetics, 2014, 66 : 299 - 310
  • [24] Vaccine-induced Gene Signature Correlates With Protection Against Acquisition in Three Independent Vaccine Efficacy Trials Including RV144
    Issac, Biju
    Ehrenberg, Philip
    Eller, Michael
    Alter, Galit
    Sekaly, Rafick
    Robb, Merlin
    Gramzinski, Robert
    Pau, Maria
    Schuitemaker, Hanneke
    Barouch, Dan
    Michael, Nelson
    Thomas, Rasmi
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 : 18 - 18
  • [25] HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trial
    Prentice, Heather A.
    Ehrenberg, Philip K.
    Baldwin, Karen M.
    Geretz, Aviva
    Andrews, Charla
    Nitayaphan, Sorachai
    Rerks-Ngarm, Supachai
    Kaewkungwal, Jaranit
    Pitisuttithum, Punnee
    O'Connell, Robert J.
    Robb, Merlin L.
    Kim, Jerome H.
    Michael, Nelson L.
    Thomas, Rasmi
    IMMUNOGENETICS, 2014, 66 (05) : 299 - 310
  • [26] The FCGR2C allele that modulated the risk of HIV-1 infection in the Thai RV144 vaccine trial is implicated in HIV-1 disease progression
    Lassauniere, Ria
    Paximadis, Maria
    Ebrahim, Osman
    Chaisson, Richard E.
    Martinson, Neil A.
    Tiemessen, Caroline T.
    GENES AND IMMUNITY, 2019, 20 (08) : 651 - 659
  • [27] The FCGR2C allele that modulated the risk of HIV-1 infection in the Thai RV144 vaccine trial is implicated in HIV-1 disease progression
    Ria Lassaunière
    Maria Paximadis
    Osman Ebrahim
    Richard E. Chaisson
    Neil A. Martinson
    Caroline T. Tiemessen
    Genes & Immunity, 2019, 20 : 651 - 659
  • [28] Genetics of Fc Gamma Receptors IIa and IIIa in vaccine trial reagents to support the study of immune correlates in RV144
    Baldwin, K.
    Cervenka, T.
    de Souza, M. S.
    Paris, R.
    Koehler, R.
    Thongcharoen, P.
    Pitisutitthum, P.
    Nitayaphan, S.
    Suriyanon, V.
    Robb, M.
    Michael, N.
    Kim, J.
    Kijak, G.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (10) : A71 - A71
  • [29] HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition
    Prentice, Heather A.
    Tomaras, Georgia D.
    Geraghty, Daniel E.
    Apps, Richard
    Fong, Youyi
    Ehrenberg, Philip K.
    Rolland, Morgane
    Kijak, Gustavo H.
    Krebs, Shelly J.
    Nelson, Wyatt
    DeCamp, Allan
    Shen, Xiaoying
    Yates, Nicole L.
    Zolla-Pazner, Susan
    Nitayaphan, Sorachai
    Rerks-Ngarm, Supachai
    Kaewkungwal, Jaranit
    Pitisuttithum, Punnee
    Ferrari, Guido
    McElrath, M. Juliana
    Montefiori, David C.
    Bailer, Robert T.
    Koup, Richard A.
    O'Connell, Robert J.
    Robb, Merlin L.
    Michael, Nelson L.
    Gilbert, Peter B.
    Kim, Jerome H.
    Thomas, Rasmi
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (296)
  • [30] Immune correlates of vaccine protection against HIV-1 acquisition
    Corey, Lawrence
    Gilbert, Peter B.
    Tomaras, Georgia D.
    Haynes, Barton F.
    Pantaleo, Giuseppe
    Fauci, Anthony S.
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (310)
12345